Dr. Mark Erlander, CEO of Cardiff Oncology discusses their lead drug candidate Onvansertib and the three active clinical trials in colorectal cancer, acute myeloid leukemia, and prostate cancer.  Onvansertib specifically targets and inhibits a downstream enzyme, PLK1, effectively stopping cancer cell division […]

DURHAM, N.C. (WNCN) – Durham-based Chimerix is on the fast track to saving lives of COVID-19 patients as experts learn more about deadly side effects for younger people. “We’ve essentially re-positioned the company to focus on getting this up and running in a matter of a few weeks,” said Chimerix CEO Mike Sherman. The drug DSTAT is […]

DURHAM, N.C. — The coronavirus attacks the body in so many ways, it has kept doctors guessing and sampling drugs they’ve used before for other purposes. Mike Sherman, the CEO of Chimerix, says it all started with a drug called DSTAT, under development to treat a serious and complicated type of cancer known as acute […]